Micro Interventional Devices, Inc. (MID), a Bethlehem, PA-based developer of structural heart repair technologies, has raised $250k in funding from The Life Sciences Greenhouse of Central Pennsylvania.
Founded in May of 2010 and led by President & CEO Michael Whitman, Micro Interventional Devices is an early stage cardiovascular medical device company. Its initial product offering is a minimally invasive device known as Permaseal™, which provides access and wound closure during structural heart repair procedures, including transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement, LVAD placement, mitral valve repair, valvuloplasty, aortic arch repair, ASD and VSD closure, left atrial appendage closure, ablation of arrhythmia, etc..
In September 2011, MID received funding from Ben Franklin Technology Venture Partners (read here)
FinSMEs
01/03/2012